Inovio Pharmaceuticals (INO)

• Market cap: $116M
• 1 day: -1.18%
• 5 days: 9.87%
• 1 month: 5.03%
• 3 months: -31.28%
• 6 months: 13.61%
• Year to date: -1.18%
• 1 year: -15.66%
• 5 years: -98.9%
• 10 years: -97.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Employees: 134